| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |